Technology is Your Teacher
Technological Weaknesses to Covid-19
artificial intelligence aka Artificial Intelligence (AI) for data mining centralized platform for image data of coronavirus patients Covid-19 who have been identified in Indonesia. Neurabot is part of the task force of artificial intelligence and information technology (Task Force AI & IT) in handling the Covid-19 pandemic in Indonesia. Director General of Small Industries, Intermediate and Assorted (IKMA) Ministry of Industry Gati Wibawaningsih said Neurabot was tasked to develop the application of deep learning technology on CT-Scan examination of the lungs as well as chest plain photo (x-ray). Neurabot can quickly detect Covid-19 cases with sensitivity and high, so it can help clinical decision-making in the current coronavirus pandemic. Founder Neurabot Indarto explained one of the weaknesses faced in the use of the technology developed is that the majority of Covid-19 referral hospitals still use plain chest photo examination (x-ray) which is low sensitivity. According to Indarto, x-ray sensitivity is lower than low-dose pulmonary CT-scan (LDCT) in detecting the picture of changes in lung structure of patients. "Although Neurabot along with AI experts who are members of this task force will still try to process all available data sources, he said, includes chest plain photo data and clinical data as boosters to produce AI-based early identification solutions appropriately and quickly,"
Technology ENTERED LIST Home National Politics Law & Criminal Events International Asean Asia Pacific Middle East Europe Economy Finance Energy Business Macro Sports Football Moto GP F1 Racket Technology Information Technology Science Telecommunications Automotive Entertainment Film Music Celeb Art Culture Music At Newsroom Lifestyle Health Food Travel Trends Focus My Column & Jakarta Music at Newsroom Most Popular Infographics Photo Video TV Index Download Apps Follow Us Home National Economy Sports Technology Entertainment Lifestyle Focus Most Popular Columns Infographics Photo Index Home Technology Information Technology Startup RI Reveals Weakness of Covid-19 RS Technology Referral CNN Indonesia Wednesday, 10/06/2020 02:00 Illustration of startup. (Istockphoto/scyther5) Jakarta, CNN Indonesia -- Domestic start-up (startup), Neurabot uses artificial intelligence technology aka Artificial Intelligence (AI) for centralized data mining platform for image data of Covid-19 coronavirus patients who have been identified in Indonesia. Neurabot is part of the task force of artificial intelligence and information technology (Task Force AI & IT) in handling the Covid-19 pandemic in Indonesia. Director General of Small Industries, Intermediate and Assorted (IKMA) Ministry of Industry Gati Wibawaningsih said Neurabot was tasked to develop the application of deep learning technology on CT-Scan examination of the lungs as well as chest plain photo (x-ray). PauseUnmute Loaded: 3.31% Fullscreen It claims Neurabot can quickly detect Covid-19 cases with sensitivity and high, so as to help clinical decision-making in the current coronavirus pandemic. Founder Neurabot Indarto explained one of the weaknesses faced in the use of the technology developed is that the majority of Covid-19 referral hospitals still use plain chest photo examination (x-ray) which is low sensitivity. According to Indarto, x-ray sensitivity is lower than low-dose pulmonary CT-scan (LDCT) in detecting the picture of changes in lung structure of patients. "Although Neurabot along with AI experts who are members of this task force will still try to process all available data sources, he said, including plain chest photo data and clinical data as an amplifier to produce AI-based early identification solutions appropriately and quickly" said Indarto quoting Antara, Monday (8/6). See also: Corona Detection Applications of Various Countries in the New Normal Era Neurabot's first solution is My Lab, the first digital image processing laboratory platform in Indonesia in the field of health and biotechnology. Through this platform, Neurabot presents a digital laboratory based on microscopic images and radiological imagery, which allows users to collaborate on research, digital image data, digitalization and data storage. The second solution Neurabot is AI Lab, which is able to process medical and biotechnological image data that has been collected with the help of artificial intelligence. The result is information in the form of prediction, calculation, identification and segmentation of an object or condition, which is useful directly when making decisions (decision support system) in the process of diagnosis of a disease, which is, including the Covid-19 pandemic.
Neurabot aims to build an ecosystem in the field of science that combines artificial intelligence technology with human intelligence, but without replacing humans. "This technology does not intend to replace an expert, but helps in the quick and precise enforcement of the diagnosis. The final decision in diagnosis is the responsibility of experts and professionals," he explained Neurabot is a startup that gets copyright in the field of 'Digital Image Processing Laboratory Platform with Artificial Intelligence Technology'. Neurabot has also won awards while representing Indonesia in several international competitions, including Asia Hardware Battle 2018, Best AI/Machine Learning and HealthTech Startup at the Rice Bowl StartUp Awards 2018, Indonesia.
